ArticleMolecular biomedicine2020

Integrin-Src-YAP1 signaling mediates the melanoma acquired resistance to MAPK and PI3K/mTOR dual targeted therapy.

Chune Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.